Pembrolizumab Alone or Combined With Chemotherapy vs Chemotherapy as First-Line Therapy for Advanced Urothelial Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Pembrolizumab Alone or Combined With Chemotherapy Versus Chemotherapy as First-Line Therapy for Advanced Urothelial Carcinoma (KEYNOTE-361): A Randomised, Open-Label, Phase 3 Trial
Lancet Oncol 2021 May 26;[EPub Ahead of Print], T Powles, T Csőszi, M Özgüroğlu, N Matsubara, L Géczi, SY Cheng, Y Fradet, S Oudard, C Vulsteke, R Morales Barrera, A Fléchon, S Gunduz, Y Loriot, A Rodriguez-Vida, R Mamtani, EY Yu, K Nam, K Imai, B Homet Moreno, A AlvaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.